Eaton Vance Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $57.8M | Buy |
177,500
+36,483
| +26% | +$13.4M | 0.09% | 227 |
|
|
2022
Q2 | $49.5M | Buy |
141,017
+15,712
| +13% | +$6.41M | 0.07% | 267 |
|
|
2022
Q1 | $68.5M | Buy |
125,305
+18,855
| +18% | +$9.92M | 0.08% | 247 |
|
|
2021
Q4 | $70.1M | Sell |
106,450
-1,191
| -1% | -$748K | 0.09% | 229 |
|
|
2021
Q3 | $65.4M | Buy |
107,641
+5,437
| +5% | +$3.65M | 0.09% | 213 |
|
|
2021
Q2 | $64.5M | Buy |
102,204
+2,943
| +3% | +$1.63M | 0.09% | 224 |
|
|
2021
Q1 | $48.6M | Buy |
99,261
+325
| +0.3% | +$163K | 0.07% | 267 |
|
|
2020
Q4 | $49.5M | Buy |
98,936
+5,156
| +5% | +$2.31M | 0.08% | 243 |
|
|
2020
Q3 | $36.9M | Sell |
93,780
-42
| -0% | -$15.5K | 0.07% | 258 |
|
|
2020
Q2 | $31M | Sell |
93,822
-30
| -0% | -$8.69K | 0.06% | 258 |
|
|
2020
Q1 | $22.7M | Sell |
93,852
-1,068
| -1% | -$279K | 0.06% | 282 |
|
|
2019
Q4 | $24.8M | Buy |
94,920
+7,963
| +9% | +$2.1M | 0.05% | 299 |
|
|
2019
Q3 | $23.6M | Sell |
86,957
-57
| -0.1% | -$15.9K | 0.05% | 286 |
|
|
2019
Q2 | $24M | Buy |
87,014
+115
| +0.1% | +$28.3K | 0.05% | 277 |
|
|
2019
Q1 | $19.4M | Sell |
86,899
-38
| -0% | -$7.84K | 0.04% | 295 |
|
|
2018
Q4 | $16.2M | Sell |
86,937
-19
| -0% | -$3.9K | 0.04% | 287 |
|
|
2018
Q3 | $21.7M | Buy |
86,956
+5,939
| +7% | +$1.44M | 0.05% | 275 |
|
|
2018
Q2 | $17.7M | Sell |
81,017
-81,133
| -50% | -$16.7M | 0.04% | 291 |
|
|
2018
Q1 | $31M | Buy |
162,150
+81,075
| +100% | +$15M | 0.04% | 311 |
|
|
2017
Q4 | $12.7M | Hold |
81,075
| – | – | 0.03% | 345 |
|
|
2017
Q3 | $12.6M | Hold |
81,075
| – | – | 0.03% | 337 |
|
|
2017
Q2 | $13.1M | Buy |
81,075
+2,459
| +3% | +$399K | 0.03% | 323 |
|
|
2017
Q1 | $12.2M | Sell |
78,616
-185
| -0.2% | -$25.5K | 0.03% | 316 |
|
|
2016
Q4 | $9.24M | Sell |
78,801
-95
| -0.1% | -$10.8K | 0.03% | 326 |
|
|
2016
Q3 | $8.89M | Hold |
78,896
| – | – | 0.03% | 322 |
|
|
2016
Q2 | $7.33M | Hold |
78,896
| – | – | 0.02% | 363 |
|
|
2016
Q1 | $6.18M | Hold |
78,896
| – | – | 0.02% | 366 |
|
|
2015
Q4 | $5.75M | Hold |
78,896
| – | – | 0.02% | 384 |
|
|
2015
Q3 | $5.86M | Buy |
78,896
+1,394
| +2% | +$99.8K | 0.02% | 382 |
|
|
2015
Q2 | $4.97M | Buy |
77,502
+700
| +0.9% | +$48.5K | 0.02% | 394 |
|
|
2015
Q1 | $5.93M | Buy |
76,802
+940
| +1% | +$73.1K | 0.02% | 376 |
|
|
2014
Q4 | $5.62M | Buy |
75,862
+10
| +0% | +$701 | 0.02% | 375 |
|
|
2014
Q3 | $4.47M | Sell |
75,852
-2,104
| -3% | -$133K | 0.01% | 410 |
|
|
2014
Q2 | $5.21M | Hold |
77,956
| – | – | 0.02% | 381 |
|
|
2014
Q1 | $4.73M | Sell |
77,956
-19,054
| -20% | -$1.14M | 0.01% | 398 |
|
|
2013
Q4 | $5.16M | Sell |
97,010
-6,950
| -7% | -$366K | 0.01% | 388 |
|
|
2013
Q3 | $5.18M | Sell |
103,960
-25,082
| -19% | -$1.21M | 0.02% | 361 |
|
|
2013
Q2 | $5.79M | Buy |
+129,042
| New | +$5.64M | 0.02% | 336 |
|
Other funds holding IDXX
Eaton Vance Management's IDXX Position: Q3 2022 in Review
Eaton Vance Management increased its Idexx Laboratories (IDXX) stake by 26% in Q3 2022, buying an estimated $13.4M and bringing the position to 177,500 shares worth $57.8M. The position accounts for 0.09% of the portfolio, ranked #227.
Eaton Vance Management first reported a position in IDXX in Q2 2013 and has held it in 38 quarters since. The position peaked at $70.1M in Q4 2021. 924 funds tracked by Wall St. Rank hold IDXX as of Q3 2022.
- Eaton Vance Management held 177,500 shares of Idexx Laboratories worth $57.8M as of Q3 2022.
- Eaton Vance Management bought 36,483 Idexx Laboratories shares in Q3 2022, an estimated $13.4M.
- Idexx Laboratories made up 0.09% of Eaton Vance Management's portfolio in Q3 2022, its #227 holding.
- Eaton Vance Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 38 quarters since.
- Eaton Vance Management's Idexx Laboratories position peaked at $70.1M in Q4 2021.
- 924 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2022.
Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.